Dr. Ryan Zarychanski, an associate professor of internal medicine, said preliminary studies have suggested hydroxychloroquine — a drug approved by Health Canada to prevent and treat malaria since the 1950s — can be repurposed to reduce the severity of COVID-19. CBC
Thursday, March 26, 2020
'We've stepped up': Manitoba researchers begin clinical trial with drug they hope can help in COVID-19 fight
Dr. Ryan Zarychanski, an associate professor of internal medicine, said preliminary studies have suggested hydroxychloroquine — a drug approved by Health Canada to prevent and treat malaria since the 1950s — can be repurposed to reduce the severity of COVID-19. CBC
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment